Association Between Financial Conflicts of Interests and Supportive Opinions for Erectile Dysfunction Treatment
- 470 Downloads
A conflict of interest (COI) is a situation in which a person has competing loyalties or interests that make it difficult to fulfil his or her duties impartially. Conflict of interest is not categorically improper in itself but requires proper management. A SCOPUS literature search was performed for publications on the efficacy/safety of Phospho-Di-Esterase Inhibitors (PDEIs) for treating erectile dysfunction. A categorization tool (CoOpCaT) was used to review and classify the publications as supportive/not-supportive for the discussed active ingredient and reporting or not reporting a COI for that specific drug or for the remaining PDEIs (i.e. competitors). Multivariable binary logistic regression was performed. In the 419 selected records the prevalence of supportive opinions was higher when a COI for the index label was declared. The CoOpCaT showed good internal consistency, discriminative validity and intra/inter-rater agreement. The strongest predictor for a supportive opinion was the total number of financial COIs for the index label. A mild protective effect of the total number of financial COIs for any competitor label was noted. Financial COIs have frequently been associated with bias, and the measures currently adopted to restrain it lack effectiveness. Some evidence for monitoring and/or compensating this bias is reported here, but the ultimate solution remains distant.
KeywordsSponsor Conflict of interest Bias Ethics Financial disclosure
The authors wish to thank Thomas Dewis who assisted in the language editing of the manuscript.
- Hair, J., R. Anderson, R. Tatham, and W. Black. 1998. Multivariate data analysis, 5th ed. New Jersey: Prentice-Hall.Google Scholar
- Institute of Medicine (US) Committee on Conflict of Interest in Medical Research Education and Practice. 2009. Conflict of interest in medical research, education, and practice. Washington (DC): National Academies Press (US).Google Scholar
- Kassirer, J.P. 2009. Medicine’s obsession with disclosure of financial conflicts: Fixing the wrong problem. In Science and the media Delgado’s brave bulls and the ethics of scientific disclosure, ed. P.J. Snyder, L.C. Mayes, and D.D. Spencer, 79–89. London, UK: Academic press.Google Scholar
- Lexchin, J. 2012. Sponsorship bias in clinical research. International Journal of Risk & Safety in Medicine 24(4): 233–242.Google Scholar
- ———. 2012b. Those who have the gold make the evidence: How the pharmaceutical industry biases the outcomes of clinical trials of medications. Science and Engineering Ethics 18(2): 247–261.Google Scholar
- Lundh, A., S. Sismondo, J. Lexchin, O.A. Busuioc, and L. Bero. 2012. Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 12(12): 1–61.Google Scholar
- Menard, S. 2001. Applied logistic regression analysis. Sage university series on quantitative applications in the social sciences. Thousand Oaks, CA: Sage Publisher.Google Scholar
- Myers, R.H. 1990. Classical and modern regression with applications. Pacific Grove, CA: Duxbury/Thompson Learning Publisher.Google Scholar
- ———. 2008. Has the hunt for conflicts of interest gone too far? Yes. BMJ 336(7642): 476.Google Scholar